New diagnostic technology showcased during Osteoporosis Awareness Month

[ad_1]

TAMPA, Florida, May 14, 2021 / PRNewswire / – Echolight Medical, present REMS diagnostic technology at Florida Orthopedic Society Annual Scientific Meeting in Tampa, Florida, May 14-15, 2021.

Widely used everywhere Europe (and now becoming available in many countries around the world), REMS is the first without radiation technology provided using a portable Bone densitometer which can safely monitor key indicators of bone health with higher frequency than other testing methods. In a few minutes, REMS provides a patient’s bone health scores and an assessment of their future fracture risk.

A superb 54 million Americans are impacted by osteoporosis and low bone density.

The sooner changes in bone density are identified, the sooner health and fitness professionals can influence patients and clients to make lifestyle changes in order to build bone mass and prevent further bone loss.

“The way we screen and diagnose patients with osteoporosis is finally changing for the better,” said Douglas tefft, President of Echolight Medical North America. “The portability and ease of use of REMS technology means that screening can begin earlier, which helps to better position patients and their healthcare providers to take meaningful action to prevent the onset of the disease. osteoporosis rather than treating the disease once fractures start to impact quality of life. “

More than half of Americans 50 years and older are at high risk of bone fracture, which osteoporosis and osteopenia an urgent public health problem. It is especially important in women, as pregnancy and menopause can lead to loss of bone density. More women die of osteoporosis each year than breast and cervical cancer combined.

Chronic health conditions such as diabetes, rheumatoid arthritis, kidney or liver disease, cancer, HIV, and lupus, along with drugs to treat these and other conditions, also lead to an increased risk of fracture.

REMS is the first clinically available direct, non-ionizing method of measuring BMD at axial sites, which include the femur and lumbar spine. Its portability has the advantage of detecting and monitoring patient bone health at the point of care, creating more opportunities for the early diagnosis and prevention of osteoporosis-related fractures.

Women from 30 with known risk factors are encouraged to speak with their health care provider to discuss bone density screening to establish a baseline before menopause.

Patients who wish to schedule a REMS analysis of talking with their health care provider.

About REMS: Ultrasound radiofrequency multispectrometry (REMS) measures bone density; and reports a T score, Z score and qualitative assessment of bone microarchitecture (independent of bone density) to predict future fracture risk – all delivered within minutes. Portable, Diagnostic and Radiation-Free Bone Health Densitometer – a safe, accurate and cost-effective medical device that elevates bone health awareness and treatment to traditional medical care. Learn more about EcholightMedical.com.

Contact: Jesse landis
[email protected]
813-846-3167

SOURCE Echolight Medical

Related links

https://www.echolightmedical.com/

[ad_2]
Source link

Comments are closed.